Analogs of thyrotropin-releasing hormone using an aminoglycine-based template

Peptides

Volumn 19, Issue 10, 1998, Pages 1679-1683

  Kirby, Dean A ^a   Wang, Wei ^b   Gershengorn, Marvin C ^b   Rivier, Jean E ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Aminoglycine derivatives; Betidamino acids; TRH analogs; TRH receptor

Indexed keywords

GLYCINE; PROTIRELIN DERIVATIVE; PROTIRELIN RECEPTOR;

ACYLATION; ARTICLE; BINDING AFFINITY; DERIVATIZATION; DNA TEMPLATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE RELEASE; HYPOPHYSIS FUNCTION; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTON TRANSPORT; SOLID PHASE EXTRACTION;

AMINO ACIDS; ANIMALS; GLYCINE; MICE; PITUITARY GLAND; PROTEIN BINDING; RECEPTORS, THYROTROPIN-RELEASING HORMONE; TEMPLATES, GENETIC; THYROTROPIN-RELEASING HORMONE;

EID: 0032424668     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00124-7     Document Type: Article

References (18)

1. Boler, J.; Enzmann, F.; Folkers, K.; Bowers, C. Y.; Schally, A. V. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem. Biophys. Res. Commun. 37:705-710; 1969.
2. Burgus, R.; Dunn, T.; Ward, D.; Vale, W.; Amoss, M.; Guillemin, R. Dérivés polypeptidiques de synthèse doués d'activité hypophysiotrope TRF. C. R. Acad. Sci. 268:2116-2118; 1969.
3. Coy, D. H.; Hirotsu, Y.; Redding, T. W.; Coy, E. J.; Schally, A. V. Synthesis and biological properties of the 2-L-β-(pyrazolyl-1)alanine analogs of luteinizing hormone-releasing hormone and thyrotropin-releasing hormone. J. Med. Chem. 18:948-949; 1975.
4. Faden, A. I.; Labroo, V. M.; Cohen, L. A. Imidazole-substituted analogues of TRH limit behavioral deficits after experimental brain trauma. J. Neurotrauma 10:101-108; 1993.
5. Jiang, G.; Miller, C.; Koerber, S. C.; Porter, J.; Craig, A. G.; Bhattacharjee, S.; Kraft, P.; Burris, T. P.; Campen, C. A.; Rivier, C. L.; Rivier, J. E. Betidamino Acid Scan of the GnRH Antagonist Acyline. J. Med. Chem. 40:3739-3748; 1997.
6. Jiang, G.-C.; Simon, L.; Rivier, J. E. Orthogonally protected N-methyl-substituted α-aminoglycines. Prot. Pept. Lett. 3:219-224; 1996.
7. 2 affinities of the complete series of analogues with single D-residue substitution. J. Med. Chem. 36:3802-3808; 1993.
8. Laakkonen, L.; Li, W.; Perlman, J. H.; Guarnieri, F.; Osman, R.; Moeller, K. D.; Gershengorn, M. C. Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone. Mol. Pharmacol. 49:1092-1096; 1996.
9. Labroo, V. M.; Vonhof, S.; Feuerstein, G. Z.; Cohen, L. A. Effect of histidine modification in TRH on binding to rat pituitary and brain receptors. In: Rivier, J. E., Marshall, G. R., Eds. Escom, Leiden, The Netherlands. 1989; pp. 127-128.
10. Li, W.; Moeller, K. D. Conformationally restricted TRH analogs: The compatibility of a 6,5-bicyclic lactam-based mimetic with binding to TRH-R. J. Am. Chem. Soc. 118:10106-10112; 1996.
11. O'Leary, R.; O'Connor, B. Thyrotropin-releasing hormone. J. Neurochem. 65:953-963; 1995.
12. Qasmi, D.; René, L.; Badet, B. An α-aminoglycine derivative suitable for solid phase peptide synthesis using Fmoc strategy. Tetrahedron Lett. 34:3861-3862; 1993.
13. Rivier, J. E.; Jiang, G.-C.; Koerber, S. C.; Porter, J.; Craig, A. G.; Hoeger, C. Betidamino acids: Versatile and constrained scaffolds for drug discovery. Proc. Natl. Acad. Sci. USA 93:2031-2036; 1996.
14. ω-triazolyl-ornithine, -lysine or -paraaminophenylalanine residues at positions 5 and 6. J. Med. Chem. 35:4270-4278; 1992.
15. 1,2: Effect of replacement or modification of histidine residue on biological activity. J. Med. Chem. 15:479-482; 1972.
16. Sievertsson, H.; Chang, J.-K.; Folkers, K. On the role of the histidine moiety in the structure of the thyrotropin-releasing hormone. J. Med. Chem. 15:219-221; 1972.
17. Szirtes, T.; Kisfaludy, L.; Pálosi, E.; Szporny, L. Synthesis of thyrotropin-releasing hormone analogues. 1. Complete dissociation of central nervous system effects from thyrotropin-releasing activity. J. Med. Chem. 27:741-745; 1984.
18. ω-cyanoguanidino moieties on selected amino functions during solid-phase peptide synthesis. J. Am. Chem. Soc. 112:9624-9626; 1990.